| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Arcutis Biotherapeutics, Inc. | Director | Common Stock | 26,735 | $822,991 | $30.78 | 24 Nov 2025 | Direct |
| Arcutis Biotherapeutics, Inc. | Director | Stock Option (right to buy) | 5,000 | 24 Nov 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ARQT | Arcutis Biotherapeutics, Inc. | 24 Nov 2025 | 5 | -$567,945 | 4 | Director | 25 Nov 2025, 18:27 |
| ARQT | Arcutis Biotherapeutics, Inc. | 12 Jun 2025 | 2 | $0 | 4 | Director | 16 Jun 2025, 20:18 |
| ARQT | Arcutis Biotherapeutics, Inc. | 14 Jun 2024 | 2 | $0 | 4 | Director | 18 Jun 2024, 16:51 |
| ARQT | Arcutis Biotherapeutics, Inc. | 31 May 2023 | 2 | $0 | 4 | Director | 02 Jun 2023, 19:22 |
| ARQT | Arcutis Biotherapeutics, Inc. | 01 Jun 2022 | 2 | $0 | 4 | Director | 03 Jun 2022, 16:54 |
| ARQT | Arcutis Biotherapeutics, Inc. | 09 Jun 2021 | 1 | $0 | 4 | Director | 16 Jun 2021, 14:07 |
| ARQT | Arcutis Biotherapeutics, Inc. | 09 Jun 2021 | 0 | $0 | 3 | Director | 16 Jun 2021, 14:06 |